NBT Analytics Competitors and Similar CompaniesClear all
Opko Health's competitors and similar companies include IntegraGen and Sysmex Inostics.
 Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. |  IntegraGen IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases. |  Sysmex Inostics Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers. | |
Founding Date | Founding Date 2007 | Founding Date 2000 | Founding Date 2008 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Miami, US HQ Woburn, US | Locations Évry, FR HQ Cambridge, US | Locations Hamburg, DE HQ Kobe, JP Baltimore, US |
Employees | Employees 6,0967% increase | Employees 4420% decrease | Employees 65 |
Valuation ($) | Valuation ($) 1.1 b | Valuation ($) 3.8 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $606.9m (FY, 2025) | Revenue (est.) €5m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $400.9m (FY, 2025) | Cost of goods €1.8m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $205.9m (FY, 2025) | Gross profit €3.5m (FY, 2025) | Gross profit N/A |
Net income | Net income ($225.7m) (FY, 2025) | Net income (€2.7m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 31m | Total funding raised $ 14.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
IntegraGen
HQ
Évry, FR
Employees
44↓ 20% decrease
IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.
View companySysmex Inostics
HQ
Hamburg, DE
Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers.
View company